
Sign up to save your podcasts
Or


Today, and all COVID episode. Does adding baricitinib improve outcomes in patients on remdesivir; convalescent plasma given early in high risk elders; and how common are long-hauler symptoms.
By Mark Ebell4.7
9292 ratings
Today, and all COVID episode. Does adding baricitinib improve outcomes in patients on remdesivir; convalescent plasma given early in high risk elders; and how common are long-hauler symptoms.

137 Listeners

700 Listeners

497 Listeners

288 Listeners

283 Listeners

262 Listeners

3,342 Listeners

1,153 Listeners

194 Listeners

86 Listeners

513 Listeners

365 Listeners

248 Listeners

370 Listeners

314 Listeners